Modular pharmacology: The next paradigm in drug discovery

Expert Opinion on Drug Discovery

Volumn 7, Issue 8, 2012, Pages 667-677

  Wang, Zhong ^a   Liu, Jun ^a   Yu, Yanan ^a   Chen, Yinying ^a   Wang, Yongyan ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Modular pharmacology; Module; Module array; Network pharmacology

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

BIOLOGY; CLINICAL PRACTICE; DRUG DEVELOPMENT; DRUG TARGETING; FEEDBACK SYSTEM; HUMAN; MODULAR PHARMACOLOGY; NONHUMAN; PHARMACOLOGY; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; DRUG DISCOVERY; HUMANS; PHARMACOLOGY;

EID: 84864357761     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.2012.692673     Document Type: Review

References (102)

1. Lord CJ, Ashworth A. Biology-driven cancer drug development: Back to the future. BMC Biol 2010;8:38
2. De Bono JS, Ashworth A. Translating cancer research into targeted therapeutics. Nature 2010;467:543-9
3. Rives AW, Galitski T. Modular organization of cellular networks. Proc Natl Acad Sci USA 2003;100:1128-33 (Pubitemid 36183967)
4. Csermely P, Ágoston V, Pongor S. The efficiency of multi-target drugs: The network approach might help drug design. TRENDS Pharmacol Sci 2005;26:178-82 (Pubitemid 40432652)
5. Jacobson TA. Myopathy with statin-fibrate combination therapy: Clinical considerations. Nat Rev Endocrinol 2009;5:507-18
6. Yeka A, Achan J, D'Alessandro U, et al. Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: An appropriate public health policy? Lancet Infect Dis 2009;9:448-52
7. Conway D, Cohen JA. Combination therapy in multiple sclerosis. Lancet Neurol 2010;9:299-308
8. Aggarwal S. Targeted cancer therapies. Nat Rev Drug Discov 2010;9:427-8
9. Fitzgerald JB, Schoeberl B, Nielsen UB, et al. Systems biology and combination therapy in the quest for clinical efficacy. Nat Chem Biol 2006;2:458-66 (Pubitemid 44266307)
10. Lorenz DM, Jeng A, Deem MW. The emergence of modularity in biological systems. Phys Life Rev 2011;8:129-60
11. Thiagalingam S. A cascade of modules of a network defines cancer progression. Cancer Res 2006;66:7379-85 (Pubitemid 44289187)
12. Cerami E, Demir E, Schultz N, et al. Automated network analysis identifies core pathways in glioblastoma. PLoS One 2010;5:e8918
13. Segal E, Friedman N, Koller D, et al. A module map showing conditional activity of expression modules in cancer. Nat Genet 2004;36:1090-8 (Pubitemid 41184471)
14. Hartwell LH, Hopfield JJ, Leibler S, et al. From molecular to modular cell biology. Nature 1999;402(6761 Suppl):C47-52
15. Kutalik Z, Beckmann JS, Bergmann S. A modular approach for integrative analysis of large-scale gene-expression and drug-response data. Nat Biotechnol 2008;26:531-9 (Pubitemid 351668039)
16. Malinauskas T, Aricescu AR, Lu W, et al. Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1. Nat Struct Mol Biol 2011;18:886-93
17. Bar-Joseph Z, Gerber GK, Lee TI, et al. Computational discovery of gene modules and regulatory networks. Nat Biotechnol 2003;21:1337-42 (Pubitemid 37356619)
18. Xu X, Wang L, Ding D. Learning module networks from genome-wide location and expression data. FEBS Lett 2004;578:297-304 (Pubitemid 39601797)
19. Segal E, Shapira M, Regev A, et al. Module networks: Identifying regulatory modules and their condition-specific regulators from gene expression data. Nat Genet 2003;34:166-76 (Pubitemid 36666927)
20. Fortunato S. Community detection in graphs. Phys Rep 2010;486:75-174
21. Wu Z, Zhao X, Chen L. Identifying responsive functional modules from protein-protein interaction network. Mol Cells 2009;27:271-7
22. Komurov K, White M. Revealing static and dynamic modular architecture of the eukaryotic protein interaction network. Mol Syst Biol 2007;3:110
23. Nykter M, Price ND, Aldana M, et al. Gene expression dynamics in the macrophage exhibit criticality. Proc Natl Acad Sci USA 2008;105:1897-900 (Pubitemid 351439436)
24. Bak P, Paczuski M. Complexity, contingency, and criticality. Proc Natl Acad Sci USA 1995;92:6689-96
25. Xiao Y, Dougherty ER. The impact of function perturbations in Boolean networks. Bioinformatics 2007;23:1265-73 (Pubitemid 47050543)
26. Kitzbichler MG, Smith ML, Christensen SR, et al. Broadband criticality of human brain network synchronization. PLoS Comput Biol 2009;5:e1000314
27. Shew WL, Yang H, Petermann T, et al. Neuronal avalanches imply maximum dynamic range in cortical networks at criticality. J Neurosci 2009;29:15595-600
28. Pasquale V, Massobrio P, Bologna LL, et al. Self-organization and neuronal avalanches in networks of dissociated cortical neurons. Neuroscience 2008;153:1354-69
29. Li H, Zhan M. Systematic intervention of transcription for identifying network response to disease and cellular phenotypes. Bioinformatics 2006;22:96-102 (Pubitemid 43057013)
30. Bullmore E, Sporns O. Complex brain networks: Graph theoretical analysis of structural and functional systems. Nat Rev Neurosci 2009;10:186-98
31. Petricoin EF, Bichsel VE, Calvert VS, et al. Mapping molecular networks using proteomics: A vision for patient-tailored combination therapy. J Clin Oncol 2005;23:3614-21
32. Kwon YK, Cho KH. Quantitative analysis of robustness and fragility in biological networks based on feedback dynamics. Bioinformatics 2008;24:987-94
33. Zimmermann GR, Lehar J, Keith CT. Multi-target therapeutics: When the whole is greater than the sum of the parts. Drug Discov Today 2007;12(1-2):34-42 (Pubitemid 46014485)
34. Karasavvas KA, Baldock R, Burger A. A criticality-based framework for task composition in multi-agent bioinformatics integration systems. Bioinformatics 2005;21:3155-63 (Pubitemid 41418469)
35. Chen Y, Zhu J, Lum PY, et al. Variations in DNA elucidate molecular networks that cause disease. Nature 2008;452:429-35 (Pubitemid 351450844)
36. Chibon F, Lagarde P, Salas S, et al. Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity. Nat Med 2010;16:781-7
37. Lehar J, Krueger A, Zimmermann G, et al. High-order combination effects and biological robustness. Mol Syst Biol 2008;4:215
38. Kapitzky L, Beltrao P, Berens TJ, et al. Cross-species chemogenomic profiling reveals evolutionarily conserved drug mode of action. Mol Syst Biol 2010;6:451
39. Kholodenko BN, Kiyatkin A, Bruggeman FJ, et al. Untangling the wires: A strategy to trace functional interactions in signaling and gene networks. Proc Natl Acad Sci USA 2002;99:12841-6
40. Xu TR, Vyshemirsky V, Gormand A, et al. Inferring signaling pathway topologies from multiple perturbation measurements of specific biochemical species. Sci Signal 2010;3(134):ra20
41. Wang Y, Di Z, Fan Y. Identifying and characterizing nodes important to community structure using the spectrum of the graph. PLoS One 2011;6:e27418
42. Kaleta C, De Figueiredo LF, Schuster S. Can the whole be less than the sum of its parts? Pathway analysis in genome-scale metabolic networks using elementary flux patterns. Genome Res 2009;19:1872-83
43. Conradi C, Flockerzi D, Raisch J, Stelling J. Subnetwork analysis reveals dynamic features of complex (bio) chemical networks. Proc Natl Acad Sci USA 2007;104:19175-80
44. Kashtan N, Alon U. Spontaneous evolution of modularity and network motifs. Proc Natl Acad Sci USA 2005;102:13773-8 (Pubitemid 41377654)
45. Ferrell JE Jr. Self-perpetuating states in signal transduction: Positive feedback, double-negative feedback and bistability. Curr Opin Cell Biol 2002;14:140-8 (Pubitemid 34219501)
46. Wolf DM, Arkin AP. Motifs, modules and games in bacteria. Curr Opin Microbiol 2003;6:125-34 (Pubitemid 36628655)
47. Meric-Bernstam F, Gonzalez-Angulo AM. Targeting the mTOR signaling network for cancer therapy. J Clin Oncol 2009;27:2278-87
48. Torkamani A, Dean B, Schork NJ, et al. Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia. Genome Res 2010;20:403-12
49. Chen ZJ, He Y, Rosa-Neto P, et al. Revealing modular architecture of human brain structural networks by using cortical thickness from MRI. Cereb Cortex 2008;18:2374-81
50. Antal MA, Bode C, Csermely P. Perturbation waves in proteins and protein networks: Applications of percolation and game theories in signaling and drug design. Curr Protein Pept Sci 2009;10:161-72
51. Kovacs IA, Palotai R, Szalay MS, et al. Community landscapes: An integrative approach to determine overlapping network module hierarchy, identify key nodes and preredict network dynamics. PLoS One 2010;5:e12528
52. Oyama M, Kozuka-Hata H, Tasaki S, et al. Temporal perturbation of tyrosine phosphoproteome dynamics reveals the system-wide regulatory networks. Mol Cell Proteomics 2009;8:226-31
53. Schramm G, Wiesberg S, Diessl N, et al. PathWave: Discovering patterns of differentially regulated enzymes in metabolic pathways. Bioinformatics 2010;26:1225-31
54. Menashe I, Maeder D, Garcia-Closas M, et al. Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. Cancer Res 2010;70:4453-9
55. Sutterlin T, Huber S, Dickhaus H, et al. Modeling multi-cellular behavior in epidermal tissue homeostasis via finite state machines in multi-agent systems. Bioinformatics 2009;25:2057-63
56. Schellenberger J, Palsson BO. Use of randomized sampling for analysis of metabolic networks. J Biol Chem 2009;284:5457-61
57. Chatterjee MS, Purvis JE, Brass LF, et al. Pairwise agonist scanning predicts cellular signaling responses to combinatorial stimuli. Nat Biotechnol 2010;28:727-32
58. Biscardi M, Caporale R, Balestri F, et al. VEGF inhibition and cytotoxic effect of aplidin in leukemia cell lines and cells from acute myeloid leukemia. Ann Oncol 2005;16:1667-74 (Pubitemid 41510142)
59. Schwieler L, Erhardt S, Erhardt C, et al. Prostaglandin-mediated control of rat brain kynurenic acid synthesis-opposite actions by COX-1 and COX-2 isoforms. J Neural Transm 2005;112:863-72 (Pubitemid 40869075)
60. Bascompte J. Ecology. Structure and dynamics of ecological networks. Science 2010;329:765-6
61. Bonneau R. Learning biological networks: From modules to dynamics. Nat Chem Biol 2008;4:658-64
62. Hellerstein MK. Exploiting complexity and the robustness of network architecture for drug discovery. J Pharmacol Exp Ther 2008;325:1-9 (Pubitemid 351439149)
63. Nepomuceno EG. Multiobjective nonlinear system identification: A case study with thyristor controlled series capacitor (TCSC). Int J Syst Sci 2004;35:537-46
64. Hoffmann A, Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol Rev 2006;210:171-86
65. Mazzocchi F. Complementarity in biology. EMBO Rep 2010;11:339-44
66. Kearns JD, Hoffmann A. Integrating computational and biochemical studies to explore mechanisms in NF-{kappa}B signaling. J Biol Chem 2009;284:5439-43
67. O'Dea E, Hoffmann A. The regulatory logic of the NF-kappaB signaling system. Cold Spring Harb Perspect Biol 2010;2(1):a000216
68. Subramanyan K. Multi-objective optimization for hybrid fuel cells power system under uncertainty. J Power Sources 2004;132(1-2):99-112 (Pubitemid 41326043)
69. Kinouchi O. Optimal dynamical range of excitable networks at criticality. Nat Phys 2006;2:348-51
70. Nishikawa T, Motter AE. Network synchronization landscape reveals compensatory structures, quantization, and the positive effect of negative interactions. Proc Natl Acad Sci USA 2010;107:10342-7
71. Buckholtz JW, Treadway MT, Cowan RL, et al. Dopaminergic network differences in human impulsivity. Science 2010;329:532
72. Tero A, Takagi S, Saigusa T, et al. Rules for biologically inspired adaptive network design. Science 2010;327:439-42
73. Farkas IJ, Korcsmaros T, Kovacs IA, et al. Network-based tools for the identification of novel drug targets. Sci Signal 2011;4(173):pt3
74. Schadt EE, Lum PY. Thematic review series: Systems biology approaches to metabolic and cardiovascular disorders. Reverse engineering gene networks to identify key drivers of complex disease phenotypes. J Lipid Res 2006;47:2601-13
75. Hache H, Wierling C, Lehrach H, et al. GeNGe: Systematic generation of gene regulatory networks. Bioinformatics 2009;25:1205-7
76. Wang YT, Huang YH, Chen YC, et al. PINT: Pathways integration tool. Nucleic Acids Res 2010;38:W124-31
77. Onat C. LPV model based gain-scheduling controller for a full vehicle active suspension system. J Vibr Control 2007;13:1629-66 (Pubitemid 47507551)
78. Yang K, Bai H, Ouyang Q, et al. Finding multiple target optimal intervention in disease-related molecular network. Mol Syst Biol 2008;4:228
79. Kaiser M, Hilgetag CC. Nonoptimal component placement, but short processing paths, due to long-distance projections in neural systems. PLoS Comput Biol 2006;2:e95
80. Yosef N, Kaufman A, Ruppin E. Inferring functional pathways from multi-perturbation data. Bioinformatics 2006;22:e539-46 (Pubitemid 44288325)
81. Li F, Li P, Xu W, et al. PerturbationAnalyzer: A tool for investigating the effects of concentration perturbation on protein interaction networks. Bioinformatics 2010;26:275-7
82. Hutt D, Balch WE. Cell biology. The proteome in balance. Science 2010;329:766-7
83. Gough NR, Wong W. Focus issue: The evolution of complexity. Sci Signal 2010;3:eg5
84. Asquith M, Powrie F. An innately dangerous balancing act: Intestinal homeostasis, inflammation, and colitis-associated cancer. J Exp Med 2010;207:1573-7
85. Kagan JC. Complementing toll signaling. Sci Signal 2010;3:pe15
86. Rebeck GW. Nontraditional signaling mechanisms of lipoprotein receptors. Sci Signal 2009;2:pe28
87. Marbach D, Prill RJ, Schaffter T, et al. Revealing strengths and weaknesses of methods for gene network inference. Proc Natl Acad Sci USA 2010;107:6286-91
88. Alarcon B, Van Santen HM. Two receptors, two kinases, and T cell lineage determination. Sci Signal 2010;3:pe11
89. Warsop A. Art, science, and the existential focus of clinical medicine. Med Hum 2002;28:74-7 (Pubitemid 36002227)
90. Molina F, Dehmer M, Perco P, et al. Systems biology: Opening new avenues in clinical research. Nephrol Dial Transplant 2010;25:1015-18
91. Woese CR. A new biology for a new century. Microbiol Mol Biol R 2004;68:173-86 (Pubitemid 38756861)
92. Gaskins HR. The art to science of cell and developmental biology in EBM. Exp Biol Med (Maywood) 2008;233:107-8 (Pubitemid 351231542)
93. Nussinov R, Tsai C, Csermely P. Allo-network drugs: Harnessing allostery in cellular networks. Trends Pharmacol Sci 2011;32:686-93
94. Welch GR, Clegg JS. From protoplasmic theory to cellular systems biology: A 150-year reflection. Am J Physiol Cell Physiol 2010;298:C1280-90
95. Hlavacek WS, Faeder JR. The complexity of cell signaling and the need for a new mechanics. Sci Signal 2009;2:pe46
96. Randall TD. Pulmonary dendritic cells: Thinking globally, acting locally. J Exp Med 2010;207:451-4
97. Auffray C, Charron D, Hood L. Predictive, preventive, personalized and participatory medicine: Back to the future. Genome Med 2010;2:57
98. Arrell DK, Terzic A. Network systems biology for drug discovery. Clin Pharmacol Ther 2010;88:120-5
99. Quayle AP, Siddiqui AS, Jones SJ. Perturbation of interaction networks for application to cancer therapy. Cancer Inform 2007;5:45-65
100. Kotaleski JH, Blackwell KT. Modelling the molecular mechanisms of synaptic plasticity using systems biology approaches. Nat Rev Neurosci 2010;11:239-51
101. Hopkins AL. Network pharmacology: The next paradigm in drug discovery. Nat Chem Biol 2008;4:682-90
102. Rosen JM, Jordan CT. The increasing complexity of the cancer stem cell paradigm. Science 2009;324:1670-3